tiprankstipranks
Alterity Therapeutics Ltd. (PRNAF)
OTHER OTC:PRNAF

Alterity Therapeutics Ltd. (PRNAF) Stock Price & Analysis

3 Followers

PRNAF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.04
Previous Close$0.02
Volume2.92K
Average Volume (3M)N/A
Market Cap
$17.32M
Enterprise Value$7.04M
Total Cash (Recent Filing)AU$15.77M
Total Debt (Recent Filing)AU$210.38K
Price to Earnings (P/E)
Beta1.38
Feb 27, 2025
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding5,245,115,318
10 Day Avg. Volume492
30 Day Avg. VolumeN/A
Standard Deviation35.80
R-Squared0.00001
Alpha5.87
Financial Highlights & Ratios
Price to Book (P/B)0.69
Price to Sales (P/S)3.89
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.61%0.00%0.00%99.39%
0.00% Other Institutional Investors
99.39% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

PRNAF FAQ

What was Alterity Therapeutics Ltd.’s price range in the past 12 months?
Alterity Therapeutics Ltd. lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
    What is Alterity Therapeutics Ltd.’s market cap?
    Currently, no data Available
    When is Alterity Therapeutics Ltd.’s upcoming earnings report date?
    Alterity Therapeutics Ltd.’s upcoming earnings report date is Feb 27, 2025 which is in 254 days.
      How were Alterity Therapeutics Ltd.’s earnings last quarter?
      Alterity Therapeutics Ltd. released its earnings results on Feb 28, 2024. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.001.
        Is Alterity Therapeutics Ltd. overvalued?
        According to Wall Street analysts Alterity Therapeutics Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Alterity Therapeutics Ltd. pay dividends?
          Alterity Therapeutics Ltd. does not currently pay dividends.
          What is Alterity Therapeutics Ltd.’s EPS estimate?
          Alterity Therapeutics Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Alterity Therapeutics Ltd. have?
          Alterity Therapeutics Ltd. has 5,245,115,000 shares outstanding.
            What happened to Alterity Therapeutics Ltd.’s price movement after its last earnings report?
            Alterity Therapeutics Ltd. reported an EPS of -$0.001 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went up 100%.
              Which hedge fund is a major shareholder of Alterity Therapeutics Ltd.?
              Currently, no hedge funds are holding shares in PRNAF
              ---

              Alterity Therapeutics Ltd. Stock Smart Score

              6
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -52.42%
              Trailing 12-Months
              Asset Growth
              -33.11%
              Trailing 12-Months

              Company Description

              Alterity Therapeutics Ltd.

              Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Bioxcel Therapeutics
              Anavex Life Sciences
              Karyopharm Therapeutics
              Axsome Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis